A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease. (Record no. 11358506)

MARC details
000 -LEADER
fixed length control field 01512 a2200409 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250514002940.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200109s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0889-2229
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1089/088922201750251981
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Riddell, L A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20010927
245 00 - TITLE STATEMENT
Title A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. AIDS research and human retroviruses
Date of publication, distribution, etc. Jun 2001
300 ## - PHYSICAL DESCRIPTION
Extent 789-97 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element AIDS-Related Opportunistic Infections
General subdivision prevention & control
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Infective Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Consumer Product Safety
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Double-Blind Method
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element HIV-1
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Interferon-gamma
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Recombinant Proteins
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Pinching, A J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hill, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ng, T T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Arbe, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lapham, G P
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ash, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Hillman, R
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Tchamouroff, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Denning, D W
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parkin, J M
773 0# - HOST ITEM ENTRY
Title AIDS research and human retroviruses
Related parts vol. 17
-- no. 9
-- p. 789-97
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1089/088922201750251981">https://doi.org/10.1089/088922201750251981</a>
Public note Available from publisher's website

No items available.